Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
ADVM - NET INCOME
Net Income ADVM - Adverum Biotechnologies, Inc.
-117 M
LAST VALUE
10.28%
2 YEAR CAGR
-10.04%
5 YEAR CAGR
-36.35%
10 YEAR CAGR